Today, the Drug Enforcement Agency (DEA) and the Department of Health and Human Services (HHS) announced that the Biden Administration’s final rule, the Expansion of Buprenorphine Treatment via Telemedicine Encounter, will now take effect December 31, 2025. The final rule was initially scheduled to take effect on February 18, 2025, and the Trump Administration delayed the effective date to March… (Marceno, March 20, 2025) #Mental and Behavioral Health, #Opioids, #Public Health